SCLN Financial Facts

Basic net income per share: 0.16
Other (expense) income, net: 108K
See Full Income Statement

Accumulated deficit: -128.8M
Cash and cash equivalents: 96.83M
See Full Balance Sheet

SciClone Pharmaceuticals, Inc. (SCLN) Earnings

  |   Expand Research on SCLN
Next EPS Date 8/11/15 *Est. EPS Growth Rate +90.0% *Last Qtr.
Average EPS % Beat Rate +175.0% Revenue Growth Rate +26.3% *Last Qtr.
Average % Move 1-Wk after EPS +11.3% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/11/15 Q115 $0.19$0.03 +$0.16$33.6M$34M N/A Details
11/10/14 Q314 $0.17$0.12 +$0.05$34.3M$34.9M Details
8/11/14 Q214 $0.20$0.10 +$0.10$32.5M$33.4M Details
5/12/14 Q114 $0.10$0.08 +$0.02$26.6M$32.2M Details
4/1/13 Q413 $0.04$0.12 -$0.08$33.1M$35.3M Details
3/12/14 Q413 $0.08$0.15 -$0.07$32.7M$38.3M Details
11/12/13 Q313 $0.18$0.15 +$0.03$35.2M$39.7M = Details
8/7/13 Q213 $0.09$0.11 -$0.02$29.81M$33.3M = Details